Table 1.
Patient demographics.
| Patients (n = 431) | |
|---|---|
| Age at onset, years (mean, s.d.) | 61.7 (9.8) |
| Num. of visits (mean, s.d.) | 11.8 (3.5) |
| Months of follow-up (mean, s.d.) | 55.5 (26.6) |
| Gender | |
| Num. of female | 149 |
| Num. of male | 282 |
| Visit (n = 5077) | |
| Total UPDRS scores (mean, s.d.) | 24.4 (11.6) |
| Total MoCA scores (mean, s.d.) | 26.6 (3.0) |
| Subtype | |
| Akinetic-rigid type | 4568 |
| Tremor-dominant type | 647 |
| Mixed type | 335 |
| Hoehn and Yahr stage | |
| 1 | 1476 |
| 2 | 3800 |
| 3 | 213 |
| 4 | 28 |
| 5 | 6 |
| Medication | |
| No drugs | 1839 |
| Levodopa | 1157 |
| Dopamine agonist | 447 |
| Other PD medication | 442 |
| Levodopa + others | 356 |
| Levodopa + Dopamine agonist | 333 |
| Dopamine agonist + others | 260 |
| Levodopa + Dopamine agonist + others | 243 |
PD Parkinson’s disease, UPDRS Unified Parkinson’s Disease Rating Scales Part III motor score.